310
Participants
Start Date
February 29, 2004
Primary Completion Date
May 31, 2012
Study Completion Date
May 31, 2012
Certolizumab Pegol (CDP870)
"Liquid for subcutaneous injection, 200 mg/ml. 400 mg at Weeks 0, 2, 4 and thereafter every 4 weeks until Week 360.~Up to 84 months of therapy in this study."
45102, Birmingham
45028, Huntsville
45044, Little Rock
45095, Orange
45101, San Francisco
45130, Colorado Springs
45094, Gainesville
45005, Hialeah
45087, Miami
45004, North Miami Beach
45016, Chicago
45037, Indianapolis
45019, Lexington
45033, Chevy Chase
45013, Laurel
45083, Rochester
45108, Jefferson City
45035, Berlin
45009, Great Neck
45070, New York
45145, Greenville
45067, High Point
45003, Raleigh
45040, Winston-Salem
45081, Cincinnati
45091, Cincinnati
45054, Dayton
45025, Mayfield Heights
45039, Oklahoma City
45041, Tulsa
45093, Hershey
45113, Germantown
45119, Nashville
45022, Houston
45073, San Antonio
45139, Salt Lake City
45052, South Ogden
45134, Charlottesville
45078, Christiansburg
45109, Norfolk
45141, Seattle
11011, Bankstown
11005, New Lambton
11017, Herston
11006, South Brisbane
11014, Lauceston
11016, Ballarat
11007, Box Hill
11002, Fitzroy
11013, Frankston
11012, Parkville
11009, Adelaide
11010, Fremantle
11015, Garran
11018, Newtown
46006, Linz
46003, Salzburg
46002, Vienna
12001, Minsk
13004, Brussels
13001, Ghent
13003, Leuven
15001, Sofia
16005, Winnipeg
16014, Halifax
16013, Toronto
16008, Montreal
18006, Hradek Kralove
18001, Ostrava
18002, Prague
18004, Prague
19004, Aalborg
19009, Copenhagen
19010, Herlev
19007, Hvidovre
19003, Vejle
20001, Tallinn
20002, Tartu
22002, Berlin
22009, Berlin
22004, Celle
22019, Frankfurt
22013, Göttingen
22017, Hanover
22015, Kiel
22016, Leipzig
22001, Minden
22012, Munich
22008, Münster
24002, Budapest
24009, Pécs
24011, Szekszárd
26004, Beersheba
26007, Haifa
26005, Petha Tikva
27001, Milan
27004, Palermo
27007, Roma
31002, Auckland
31001, Christchurch
31005, Hamilton
31004, Milford
31003, Tauranga
32005, Oslo
32008, Oslo
32004, Tromsø
33008, Bydgoszcz
33003, Gdansk
33018, Lublin
33013, Szczecin
33007, Warsaw
33009, Warsaw
34017, Lipetsk
34006, Moscow
34016, Nizhny Novgorod
34001, Saint Petersburg
34005, Saint Petersburg
34007, Saint Petersburg
34013, Saint Petersburg
35001, Belgrade
35002, Belgrade
35004, Belgrade
36002, Singapore
38001, Celje
38003, Ljubljana
39013, Johannesburg
39003, Cape Town
39016, Cape Town
39018, Cape Town
39012, Goodwood
39010, Johannesburg
39008, Midrand
39004, Port Elizabeth
39006, Pretoria
39009, Pretoria
39014, Pretoria
39019, Pretoria
40009, Barcelona
43008, Dniepropetrovsk
43003, Lviv
43006, Odesa
UCB Pharma SA
INDUSTRY